EUVIMEDEUVIMED entdecken
Systematische Übersicht

The efficacy of various Enoxaparin dosing regimens in general surgery patients: A systematic review

Abdul Hafiz Al Tannir, Elise A Biesboer, Courtney J Pokrzywa, Juan Figueroa, Eric Harding, Marc A de Moya, Rachel S Morris, Patrick B Murphy

Surgery · 2023

DOI: 10.1016/j.surg.2023.04.032 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Surgery, 2023. Verfasst von Abdul Hafiz Al Tannir und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Trauma and Acute Care Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI. Hauptthemen laut MEDLINE: Enoxaparin, Venous Thromboembolism. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients undergoing surgical procedures are at an increased risk of venous thromboembolism events. A fixed Enoxaparin dosing regimen is the standard of care for chemoprophylaxis in most institutions; however, breakthrough venous thromboembolism events are still reported. We aimed to systematically review the literature to determine the ability of various Enoxaparin dosing regimens to achieve adequate prophylactic anti-Xa levels for venous thromboembolism prevention in hospitalized general surgery patients. Additionally, we aimed to assess the correlation between subprophylactic anti-Xa levels and the development of clinically significant venous thromboembolism events. METHODS: A systematic review was conducted using major databases from January 1, 1993, to February 17, 2023. Two independent researchers screened titles and abstracts, followed by a full-text review. Articles were included if Enoxaparin dosing regimens were evaluated by anti-Xa levels. Exclusion criteria included systematic reviews, pediatric population, nongeneral surgery (defined as trauma, orthopedics, plastics, and neurosurgery), and non-Enoxaparin chemoprophylaxis. The primary outcome was peak Anti-Xa level measured at steady state concentration. The risk of bias was assessed using the Risk of Bias in Nonrandomized studies-of Intervention tool. RESULTS: A total of 6,760 articles were extracted, of which 19 were included in the scoping review. Nine studies included bariatric patients, whereas 5 studies explored abdominal surgical oncology patients. Three studies assessed thoracic surgery patients, and 2 studies included patients undergoing "general surgery" procedures. A total of 1,502 patients were included. The mean age was 47 years, and 38% were males. The percentages of patients reaching adequate prophylactic anti-Xa levels were 39%, 61%, 15%, 50%, and 78% across the 40 mg daily, 40 mg twice daily, 30 mg twice daily, and weight-tiered, and body mass index-based groups, respectively. The overall risk of bias was low to moderate. CONCLUSION: Fixed Enoxaparin dosing regimens are not correlated with adequate anti-Xa levels in general surgery patients. Additional research is warranted to assess the efficacy of dosing regimens based on novel physiologic parameters (such as estimated blood volume).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EnoxaparinVenous ThromboembolismChildMaleHumansMiddle AgedFemaleAnticoagulantsHeparin, Low-Molecular-WeightBody Mass Index

Substanzen

EnoxaparinAnticoagulantsHeparin, Low-Molecular-Weight

Autor:innen und Institutionen

  • Division of Trauma and Acute Care Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI.
  • Division of Trauma and Acute Care Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI. Electronic address: pmurphy@mcw.edu.

Zitieren

APA

Al Tannir, A. H., Biesboer, E. A., Pokrzywa, C. J., Figueroa, J., Harding, E., de Moya, M. A., Morris, R. S., & Murphy, P. B. (2023). The efficacy of various Enoxaparin dosing regimens in general surgery patients: A systematic review. Surgery. https://doi.org/10.1016/j.surg.2023.04.032

Vancouver

Al Tannir AH, Biesboer EA, Pokrzywa CJ, Figueroa J, Harding E, de Moya MA, et al. The efficacy of various Enoxaparin dosing regimens in general surgery patients: A systematic review. Surgery. 2023. doi:10.1016/j.surg.2023.04.032

BibTeX
@article{AlTannir2023,
  author = {Al Tannir, Abdul Hafiz and Biesboer, Elise A and Pokrzywa, Courtney J and Figueroa, Juan and Harding, Eric and de Moya, Marc A and Morris, Rachel S and Murphy, Patrick B},
  title = {The efficacy of various Enoxaparin dosing regimens in general surgery patients: A systematic review},
  journal = {Surgery},
  year = {2023},
  doi = {10.1016/j.surg.2023.04.032}
}
Kostenlos starten →